|
PDIA6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.931000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.369700E-02 |
| Normal-vs-Stage2 |
7.644000E-01 |
| Normal-vs-Stage3 |
1.587610E-01 |
| Normal-vs-Stage4 |
8.900800E-01 |
| Stage1-vs-Stage2 |
1.956030E-01 |
| Stage1-vs-Stage3 |
3.999900E-02 |
| Stage1-vs-Stage4 |
3.697800E-01 |
| Stage2-vs-Stage3 |
3.014400E-01 |
| Stage2-vs-Stage4 |
9.639200E-01 |
| Stage3-vs-Stage4 |
4.596600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.770800E-01 |
| Normal-vs-AfricanAmerican |
7.599400E-01 |
| Normal-vs-Asian |
4.222000E-01 |
| Caucasian-vs-AfricanAmerican |
8.295000E-01 |
| Caucasian-vs-Asian |
1.306590E-01 |
| AfricanAmerican-vs-Asian |
3.953000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.857100E-03 |
| Normal-vs-Female |
1.560970E-03 |
| Male-vs-Female |
8.57960000044677E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.197800E-01 |
| Normal-vs-Extreme_Weight |
7.160400E-03 |
| Normal-vs-Obese |
4.820400E-01 |
| Normal-vs-Extreme_Obese |
2.859200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.874400E-01 |
| Normal_Weight-vs-Obese |
2.404200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.643000E-01 |
| Extreme_Weight-vs-Obese |
1.203610E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.861600E-01 |
| Obese-vs-Extreme_Obese |
1.944430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.450030E-01 |
| Normal-vs-Age(41-60Yrs) |
8.319800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.370760E-01 |
| Normal-vs-Age(81-100Yrs) |
1.469180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.689800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.187900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.742500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.250030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.232800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.131200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.582120E-02 |
| Normal-VS-Type2 PRCC |
9.573200E-01 |
| Normal-VS-KIRP CIMP |
5.584900E-03 |
| Normal-VS-Unclassified PRCC |
2.617000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.060630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.28439999746988E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
3.345700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.017400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.093200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.337700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.462300E-02 |
| Normal-vs-N1 |
6.416100E-02 |
| Normal-vs-N2 |
2.905800E-01 |
| N0-vs-N1 |
1.641690E-02 |
| N0-vs-N2 |
2.281800E-01 |
| N1-vs-N2 |
4.943200E-01 |
|
|
